PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Overview | Financials
Company Name PMV Pharmaceuticals, Inc.
Symbol PMVP
Currency USD
Price 1.26
Market Cap 65,436,336
Dividend Yield 0%
52-week-range 1.2 - 2.26
Industry Biotechnology
Sector Healthcare
CEO Dr. David H. Mack Ph.D.
Website https://www.pmvpharma.com

An error occurred while fetching data.

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is

Related Stocks

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

0.27 USD

Inogen, Inc. logo

Inogen, Inc.

INGN

7.88 USD

Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

RANI

1.53 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

16.01 USD

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

1.34 USD

Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

EGRX

1.03 USD

Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

KNSA

22.5 USD

Coherus BioSciences, Inc. logo

Coherus BioSciences, Inc.

CHRS

0.98 USD

Financials

Numbers are in millions USD

Numbers are in millions USD